Topic: USE OF AN IN-VITRO DIAGNOSTIC TO GUIDE CHEMOTHERAPY SELECTION IN CANCE

USE OF AN IN-VITRO DIAGNOSTIC TO GUIDE CHEMOTHERAPY SELECTION IN CANCER PATIENTS
Our doctor Dr  schreibman believes this is cutting edge. For solid tumors. You send your blood to a lab affiliate with John Hopkins and essentially they try to match your metastatic circulating cancer cells with the best therapy. He is finding at Afinitor for example is having huge success surprisingly.
Thoughts?